Literature DB >> 8812650

Chemokine Receptors: Cloning Strategies

.   

Abstract

Chemokines activate leukocytes by binding to G protein-coupled receptors on the cell surface. Cloning DNA that codes for chemokine receptors is important because it can lead rapidly to detailed information about their structure, function, expression, regulation, and evolution, information that often cannot be obtained as readily or as precisely by studying the native protein directly. Many cloning strategies can be used; however, three common elements are required: (i) a library of cloned DNA molecules from an appropriate source; (ii) a gene transfer method for producing the receptor in a naive cell type; and (iii) functional assays to identify relevant clones or to qualify clones identified by other means. A particularly productive cloning strategy has been to isolate from a relevant library those DNA molecules that have sequence similarity to closely related G protein-coupled receptors and then to screen their encoded products with chemokine functional assays. This strategy has been used for five of the six known human leukocyte chemokine receptors, and two herpesvirus-encoded chemokine receptors. The cloning strategy that will lead most rapidly to success cannot be known a priori, since idiosyncratic properties of each receptor can foil even the most rational approach.

Entities:  

Year:  1996        PMID: 8812650     DOI: 10.1006/meth.1996.0084

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

1.  Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.

Authors:  Jun Zeng; Xudan Yang; Lin Cheng; Rui Liu; Yunlong Lei; Dandan Dong; Fanghua Li; Quek Choon Lau; Longfei Deng; Edouard C Nice; Ke Xie; Canhua Huang
Journal:  J Transl Med       Date:  2013-01-07       Impact factor: 5.531

2.  Genomic organization, annotation, and ligand-receptor inferences of chicken chemokines and chemokine receptor genes based on comparative genomics.

Authors:  Jixin Wang; David L Adelson; Ahmet Yilmaz; Sing-Hoi Sze; Yuan Jin; James J Zhu
Journal:  BMC Genomics       Date:  2005-03-24       Impact factor: 3.969

3.  The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.

Authors:  Xiangde Li; Qiulu Zhong; Danjing Luo; Qinghua Du; Wenqi Liu
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.